The FDA is adding a general warning to testosterone products due to the risk of blood clots. Blood clots can form in the veins and cause a pulmonary embolism, a potentially life-threatening event that occurs when the clot travels to the lungs. The new warning is not related to the FDA’s ongoing evaluation of possible links between testosterone therapy and risk of a heart attack, stroke and death in those taking testosterone products.
If you or someone you know has suffered adverse effects from testosterone therapy, we welcome your inquiry. The Product Liability attorneys here at SGB would be happy to provide a prompt and confidential evaluation of your case.